A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left">Exploratory factor</td><td class="align_center">1 point</td><td class="align_center">2 points</td><td class="align_center">3 points</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">HBeAg (S/CO)</td><td class="align_center">&gt;1248</td><td class="align_center">106–1248</td><td class="align_center">&lt;106</td></tr><tr><td class="align_left">LSM (kPa)</td><td class="align_center">&lt;4.9</td><td class="align_center">4.9–8.5</td><td class="align_center">&gt;8.5</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>LSM: liver stiffness measurement. Score = the point of HBeAg + the point of LSM. Score 2–3: nonsignificant fibrosis; score 4: indeterminate fibrosis; and score 5–6: significant fibrosis.<br/></div></td></tr></table>

<div>Point assignment of the score system for noninvasive diagnosis of liver fibrosis.</div>

Disease Markers

tab4

Table 4

Table 4: A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels 

Table 4 | A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels 